chr17-76007403-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001988.4(EVPL):c.5802C>A(p.His1934Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000429 in 1,603,868 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 1 hom. )
Consequence
EVPL
NM_001988.4 missense
NM_001988.4 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
EVPL (HGNC:3503): (envoplakin) This gene encodes a member of the plakin family of proteins that forms a component of desmosomes and the epidermal cornified envelope. This gene is located in the tylosis oesophageal cancer locus on chromosome 17q25, and its deletion is associated with both familial and sporadic forms of oesophageal squamous cell carcinoma. Patients suffering from the autoimmune mucocutaneous disorder, paraneoplastic pemphigus, develop antibodies against the encoded protein. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2637744).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVPL | ENST00000301607.8 | c.5802C>A | p.His1934Gln | missense_variant | 22/22 | 1 | NM_001988.4 | ENSP00000301607.3 | ||
EVPL | ENST00000586740.1 | c.5868C>A | p.His1956Gln | missense_variant | 22/22 | 1 | ENSP00000465630.1 | |||
EVPL | ENST00000589231.1 | c.39C>A | p.His13Gln | missense_variant | 1/2 | 3 | ENSP00000467717.1 | |||
EVPL | ENST00000587569.5 | n.6271C>A | non_coding_transcript_exon_variant | 20/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
41
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000254 AC: 63AN: 247978Hom.: 0 AF XY: 0.000224 AC XY: 30AN XY: 133982
GnomAD3 exomes
AF:
AC:
63
AN:
247978
Hom.:
AF XY:
AC XY:
30
AN XY:
133982
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000446 AC: 647AN: 1451530Hom.: 1 Cov.: 31 AF XY: 0.000426 AC XY: 307AN XY: 720388
GnomAD4 exome
AF:
AC:
647
AN:
1451530
Hom.:
Cov.:
31
AF XY:
AC XY:
307
AN XY:
720388
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000269 AC: 41AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74496
GnomAD4 genome
AF:
AC:
41
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
29
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2024 | The c.5802C>A (p.H1934Q) alteration is located in exon 22 (coding exon 22) of the EVPL gene. This alteration results from a C to A substitution at nucleotide position 5802, causing the histidine (H) at amino acid position 1934 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.
REVEL
Uncertain
Sift
Benign
.;D;.
Sift4G
Benign
T;D;T
Polyphen
0.99
.;D;.
Vest4
0.40, 0.52
MutPred
0.55
.;Gain of disorder (P = 0.1544);.;
MVP
MPC
0.75
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at